BenevolentAI announces 3-year collaboration expansion with AstraZeneca focused on systemic lupus erythematosus and heart failure
LONDON, Jan. 13, 2022 /PRNewswire/ -- BenevolentAI, a leading clinical-stage AI drug discovery company, has expanded its AI-driven drug discovery ...